Sharechat Logo

Record year in 2014 for mid-cap private equity deals: report

Thursday 14th May 2015

Text too small?

The NZX listings of Scales Corp, Metroglass and Orion Health by their private equity owners was a major factor in a record year for mid-market PE and venture capital deals, as measured by accounting firm EY for the New Zealand Venture Capital Association.

The 14th annual Private Equity and Venture Capital Monitor publication, published this week, shows the total value of investment and divestments in the mid-market valuation range was $243.5 million, compared with $191.3 million and rivalled only in 2011, when deals worth $223 million were recorded.

The average deal size across the 19 transactions considered was $12.8 million, also a record for the survey, which was first conducted in 2003 and "mid-market divestment activity inceased significantly in 2014 to its highest ever levels, driven by IPO's," the report says, citing the partial listing of Scales Corp and Orion Health Care by Auckland PE investors Direct Capital and Pioneer Capital respectively, and the NZX listings of Metroglass involving Australian PE investor Crescent Capital, and 

"Direct Capital and Pioneer Capital have retained shareholdings post listing," the report says. "The outlook for 2015 promises further IPO opportunities for portfolio companies."

At 62 transactions and a total deal value of $55.8 million, investment and divestment at the small capital, VC end of the market was similar to the previous year, with totals fluctuating significantly from year to year. 

There were no large company buy outs during the year, whereas in 2013 transactions at the large end of the PE market totalled $210 million and included AMP Capital's purchase of a stake in Powerco.

The survey results are not comprehensive and the authors acknowledge awareness of other transactions.  It draws on a survey of 12 New Zealand and Australian private equity and venture capital firms.

Commenting on investor sentiment, the report shows unusually low levels of investment in bio-tech ventures, although the sector remains a top area of interest, along with food and beverage plays.  IT, which accounts for the lion's share of activity in 2014, "appears to have polarised fund managers," the report says.

"Fund managers have a relatively pessimistic view of the manufacturing and media/communications sectors."

 

 

 

 

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Spark New Zealand appoints new director to the Spark Board
AFT to announce full year results on May 23 2024
CRP - Korella North Takes Another Two Steps Forward
May 3rd Morning Report
ASB workers to strike as bank proposes an effective pay cut
Rising tides, sinking stocks: study explores cost of climate change
May 2nd Morning Report
AGL - Change in Senior Management
Devon Funds Morning Note - 01 May 2024
Rick Christie to step-aside as a non-executive director